Malignant ameloblastoma or ameloblastic carcinoma
PJ Slootweg, H Müller - Oral Surgery, Oral Medicine, Oral Pathology, 1984 - Elsevier
The World Health Organization defines malignant ameloblastoma as a lesion exhibiting
features of an ameloblastoma in primary and metastatic growths. To cases collected from the …
features of an ameloblastoma in primary and metastatic growths. To cases collected from the …
Gain-of-Function Mutations in the Tumor Suppressor Gene p53
MGCT van Oijen, PJ Slootweg - Clinical cancer research, 2000 - AACR
The tumor suppressor protein p53 is a multifunctional transcription factor involved in the
control of cell cycle progression, DNA integrity, and cell survival. p53 is mutated in half of all …
control of cell cycle progression, DNA integrity, and cell survival. p53 is mutated in half of all …
Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits?
MGCT van Oijen, PJ Slootweg - Cancer Epidemiology Biomarkers & …, 2000 - AACR
… Van Oijen MGCT, Rijksen G., ten Broek FW, Slootweg PJ Increased expression of
epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas …
epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas …
An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas
P Roepman, LFA Wessels, N Kettelarij, P Kemmeren… - Nature …, 2005 - nature.com
Metastasis is the process by which cancers spread to distinct sites in the body. It is the
principal cause of death in individuals suffering from cancer. For some types of cancer, early …
principal cause of death in individuals suffering from cancer. For some types of cancer, early …
An analysis of the interrelationship of the mixed odontogenic tumors—ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas
PJ Slootweg - Oral Surgery, Oral Medicine, Oral Pathology, 1981 - Elsevier
The mixed odontogenic tumors—ameloblastic fibroma, ameloblastic fibro-odontoma, and
the odontomas—represent a group of lesions of which some are neoplastic and some are …
the odontomas—represent a group of lesions of which some are neoplastic and some are …
p53 protein and Ki‐67 reactivity in epithelial odontogenic lesions. An immunohistochemical study
PJ Slootweg - Journal of oral pathology & medicine, 1995 - Wiley Online Library
Forty‐five examples of epithelial odontogenic lesions (9 ameloblastomas (AB): 13 odontogenic
keratocysts (OKC): 15 dentigerous cysts (DC): 6 radicular cysts (RC): and 2 odontogenic …
keratocysts (OKC): 15 dentigerous cysts (DC): 6 radicular cysts (RC): and 2 odontogenic …
Juvenile ossifying fibroma. An analysis of 33 cases with emphasis on histopathological aspects
PJ Slootweg, AK Panders, R Koopmans… - Journal of oral …, 1994 - Wiley Online Library
Juvenile ossifying fibroma (JOF) is a maxillofacial fibro‐osseous lesion that may show cell‐rich
osteoid strands or psammoma‐like ossicles. Whether both types are variants of a single …
osteoid strands or psammoma‐like ossicles. Whether both types are variants of a single …
Maxillofacial fibro-osseous lesions: classification and differential diagnosis.
PJ Slootweg - Seminars in diagnostic pathology, 1996 - europepmc.org
A large diversity of lesions may involve the maxillofacial bones. Some occur exclusively at
this site. Other lesions at this location have features that are different from similar lesions …
this site. Other lesions at this location have features that are different from similar lesions …
[BOEK][B] Pathology of the Head and Neck
A Cardesa, PJ Slootweg, N Gale, A Franchi - 2006 - Springer
This book provides a comprehensive description of the pathology of the head and neck region,
concentrating especially on those pathologic entities that are unique to or characteristic …
concentrating especially on those pathologic entities that are unique to or characteristic …
The ameloblastoma, the controversial approach to therapy
H Müller, PJ Slootweg - Journal of maxillofacial surgery, 1985 - Elsevier
An investigation into the length of time which elapses after the treatment of an ameloblastoma
before a recurrence becomes visible, has established that this only exceeds 5 years in 5 …
before a recurrence becomes visible, has established that this only exceeds 5 years in 5 …